Lutetium-177 PSMA therapy for prostate cancer + Ga-68 PSMA PET scan | 1 cycle - VIP package | Helios Clinic Berlin-Buch, Germany

Lutetium is commonly used for castration-resistant advanced metastatic prostate cancer. The drug itself is a liquid with a radioactive material. LU-177 PSMA treatment aims to kill cancer cells by beta radiation from the isotope Lutetium-177. The radioactive particle binds specifically to prostate cancer cells regardless of their location. As a result, the drug destroys the primary tumor and distant metastases. Our doctors perform blood tests and assess liver and kidney function before the procedure. But first, a Ga-68 PSMA PET scan is performed to detect all metastases and assess how well the malignant cells in question accumulate the PSMA tracer. A PET scan is essential to successful treatment planning and further results tracking. Note that the package includes all required pre-procedure diagnostics. Our team guarantees that the most qualified physicians perform each diagnostic step in our VIP package. Before the treatment, the patient will be hospitalized in a private room with all required amenities. In addition, an accompanying person may stay with him. During the therapy, the patient is injected intravenously for 20 minutes with the Lutetium medication. After that, he stays in a closed ward protected from radiation for two days because he is a beta radiation source. During the action of the radionuclide, he receives drugs to protect the thyroid gland and kidneys, and copious drinking, if necessary, to reduce nausea and vomiting. The patient can take personal belongings to the ward. They will not become radioactive. The radiation zone does not exceed 1 millimeter. A day after therapy, the patient undergoes a control examination, dosimetry, and a kidney scintigraphy. The therapy is particularly suitable for patients with advanced prostate cancer following standard therapies such as antihormonal therapy, chemotherapy, and radiation therapy. The side effects are minimal, and the therapy is very well tolerated. Doctors achieve reduced prostate cancer metastases, up to complete remission, with Lu 177 treatment results. However, repeating a couple of sessions at several-month intervals might be required. Our team at Helios Clinic in Berlin comprises a nuclear medicine department that specializes in radiopharmaceuticals. Our chief doctor has over 30 years of experience coordinating care with a urology and oncology department. The clinic is an all-inclusive service before Lu-177 treatment. This involves Ga-68 PSMA PET performed before therapy in the same building and simultaneously accessed by our doctors. The clinic offers a comfortable stay, an affiliation with Charité University, and access to the MSB Medical School Berlin campus for the best possible outcome. In addition, Prof. Dresel is an active associate Professor at the LMU Munich. Our team has designed a special offer for the most demanding patients. A luxury car waiting for you upon arrival at the airport, a private VIP room for you and your companion, and the most experienced doctors at each step of treatment. At the end of the treatment, our team offers a private VIP transfer back to the airport designed for maximum comfort and fast arrangements. Moreover, the deal includes special health insurance to cover any unforeseen medical issues during the trip.